BackEssex Bio-Technology Limited Overview

Essex Bio-Technology Limited Receivables

Essex Bio-Technology Limited's receivables is $740M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$740.97M
↑ 7.09% YoYΔ $49.06M vs prior year quarter

Peer trimmed avg / median

Loading

Essex Bio-Technology Limited Receivables History

Loading

Essex Bio-Technology Limited vs. peers: Receivables Comparison

Loading

Essex Bio-Technology Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Essex Bio-Technology Limited (1061.HK) FAQ

Essex Bio-Technology Limited posts a receivables of $740M as of June 2026. That compares with $690M in the prior-year period — up 7.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Essex Bio-Technology Limited's receivables was $690M. The latest reading is $740M — a 7.1% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Essex Bio-Technology Limited's financial statement story. At $740M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 1061.HK's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Essex Bio-Technology Limited's other metric pages and overview cover the third.